Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics

Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics

Paclitaxel (PTX) and 5-fluorouracil (5-FU) are clinically relevant chemotherapeutics, but both suffer a range of biopharmaceutical challenges (e.g., either low solubility or permeability and limited controlled release from nanocarriers), which reduces their effectiveness in new medicines. Anticancer...

Full description

Bibliographic Details
Main Authors: Md. Musfizur Hassan, Bilquis Romana, Guangzhao Mao, Naresh Kumar, Fabio Sonvico, Pall Thordarson, Paul Joyce, Kristen E. Bremmell, Timothy J. Barnes, Clive A. Prestidge
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Pharmaceutics
Subjects:
paclitaxel
5-fluorouracil
liposomes
micelles
liposome-micelle hybrid
cancer cell uptake
Online Access:https://www.mdpi.com/1999-4923/15/7/1886

Internet

https://www.mdpi.com/1999-4923/15/7/1886

Similar Items